Skip to main content

Correction: Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

The Original Article was published on 09 September 2021

Correction: Molecular Neurodegeneration 16, 63 (2021)

The authors wish to correct an error in Fig. 7A of the original article [1]. We have determined that the representative image of a hemibrain shown for 10 month-old, PBS-injected, nontransgenic (nTg) mice in panel A is incorrect. Due to a labeling error of the digital file name, the brain image shown was actually from a 10 month-old, PBS-injected, wild-type αSyn (M20) animal. The corrected panel for Fig. 7A is provided in the figure shown below. It is imperative to emphasize that this correction does not alter the conclusions presented in the paper. None of the 10 month-old nTg or M20 mice injected with PBS exhibited appreciable pathology.

Fig. 7
figure 1

Exacerbation of Microgliosis in αSyn PFF-seeded dTg mice. A Representative images showing IHC using antibodies specific for Iba1 to compare nTg, M20, L85, and dTg mice injected with PBS or αSyn PFFs at 8 (2 m.p.i.) and 10 months (4 m.p.i.) of age as indicated, and corresponding heatmap depicting regional Iba1 percent positivity. The increase in microglial proliferation is illustrated by the color change from blue (minimum of Iba1 percent positivity) to orange (maximum of Iba1 percent positivity). Gray indicates regions were not quantified during this study. B Quantitation of Iba1 percent positivity comparing the retrosplenial cortex, CA1 of the hippocampus, and the entorhinal cortex within each cohort. Two-Way ANOVA followed by Holm-Sidak’s multiple comparisons test was used for statistical analysis (n = 8,8,13; 6,8,12; 8,8,10; 6,8,11). Data are presented as mean + / − SEM. Scale bar: 500 μm

The authors sincerely regret any confusion this oversight may have caused and appreciate the understanding of the readership.


  1. Lloyd GM, Dhillon J-KS, Gorion K-MM, Riffe C, Fromholt SE, Xia Y, et al. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model. Mol Neurodegener. 2021;16:63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Benoit I. Giasson or David R. Borchelt.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lloyd, G.M., Dhillon, JK.S., Gorion, KM.M. et al. Correction: Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model. Mol Neurodegeneration 19, 17 (2024).

Download citation

  • Published:

  • DOI: